To summarize the interplay between ferroptosis and immune responses in central nervous system disorders, particularly in therapeutic contexts, and explore strategies targeting this axis.
Key Findings:
Ferroptosis is driven by iron-dependent lipid peroxidation and significantly influences the inflammatory-immune microenvironment in CNS diseases such as Alzheimer's and Parkinson's.
Pro-inflammatory cytokines from activated microglia can promote ferroptosis in neurons by upregulating iron transporters, contributing to neurodegeneration.
In glioma, immune responses can induce ferroptosis in tumor cells, suggesting a potential therapeutic vulnerability that could be exploited.
Interpretation:
The interplay between ferroptosis and immune responses creates a feedback loop that exacerbates neuroinflammation and tissue damage, highlighting the importance of targeting this axis for therapeutic interventions in CNS disorders.
Limitations:
Current understanding of ferroptosis-immune crosstalk is limited by the cellular heterogeneity of the CNS, as seen in studies focusing on bulk analyses.
Most studies rely on bulk analyses that do not capture cell type-specific dynamics, complicating the interpretation of findings.
The spatiotemporal coordination of ferroptosis and immune responses remains poorly defined, with few studies addressing this complexity.
Conclusion:
Targeting the ferroptosis-immune axis may offer new therapeutic avenues for CNS disorders, but further research is urgently needed to elucidate the underlying mechanisms and their implications for treatment.
A Keck Medicine of USC breast surgeon discusses the FDA’s decision — and whether using HRT to treat menopause symptoms actually affects breast cancer risk.
